Forecast Insight: Asthma/copd - Little Long-term Future For Long-acting Single-agent Inhalers

By Author: Manjula Menon
Total Articles: 1486
Comment this article

The respiratory market will continue to grow with the same rate over the next few years, with a slight dip between 2012 and 2015 due to the patent expiries of leading products. Growth is driven by the expansion of sales in existing classes, the launch of major new products with safety and convenience advantages, and the results of several landmark trials.

Scope of this report

Indication based forecasts for asthma/COPD products and significant pipeline drugs

Assessment of country-specific drivers and resistors likely to impact the market

Future market outlook for individual products taking into account key market events, in particular patent expiry and competitor launch dates

Market overview by geographical area, with value analysis of clinical and commercial factors underlying product performance

Research and analysis highlights

It expects Asthma/COPD sales in the seven major markets to grow to about $25 billion annually by 2017, with a dip between 2012 and 2015 due to patent expiries of key products. The ICS/LABA class is set to remain the leading class by value throughout, ...
... while the LAMA market will experience the strongest growth, particularly in COPD.

Novartis/Schering-Plough's once-daily ICS/LABA product will be the top-selling single brand in the seven major markets in 2017. However, the combined sales of GSK's Advair franchise (Advair/Seretide and once-daily Beyond Advair) will dominate the asthma/COPD market over the next ten years.

The phase-out of CFC-containing inhalers in the US after 2008 will have a big impact on the market for short-acting beta2-agonists (SABAs), increasing this class' size significantly. The main beneficiary is expected to be Teva/UCB's Salamol/ProAir due to its favorable price compared with other marketed HFA SABAs.

For more information Kindly visit the website : http://www.bharatbook.com/detail.asp?id=82019

Or Contact us on :
Tel No : (+9122 )27578668 , 27579438
Fax: (+9122 )27579131

Address :
Bharat Book Bureau,
207,Hermes Atrium,
Sector-11
P.O Box 54,
CBD Belapur,
Navi Mumbai - 400614.

Bharat BooK Bureau is the leading market research information aggregator which provides reports, Company profiles, newletters, country info. and online databases for the past twenty years to corportate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Bharat Book Bureau provides strategic information tools to the executives, business analysts, and knowledge managers that will help them to probe into and support critical, timely business decisions and strategies. It helps global companies to know different market before starting up business / expanding in different countries across the world. www.bharatbook.com is one stop shop for the business intelligence information requirements.